ORAGENICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
ORAGENICS, INC. (OGEN) had Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized of 7.50 million shares as of 2017-12-31, per its 10-K filed 2018-02-16.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized · last filed 2018-02-16
- 2017-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 7.50M shares.
- 2017-05-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 5.50M shares.
- 2016-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 4.00M shares.
- 2015-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 4.00M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized |
|---|---|
| 2017-12-31 | 7.50M shares 10-K · filed 2018-02-16 |
| 2017-05-31 | 5.50M shares 10-K · filed 2018-02-16 |
| 2016-12-31 | 4.00M shares 10-K · filed 2017-02-27 |
| 2015-12-31 | 4.00M shares 10-K · filed 2016-03-30 |
| 2014-12-31 | 4.00M shares 10-K · filed 2015-02-27 |
| 2013-12-31 | 4.00M shares 10-K · filed 2014-02-28 |
| 2012-07-30 | 43.08K shares 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |